[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@Mufaso7 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::984787662656688128.png) @Mufaso7 Mufaso

Mufaso posts on X about $vktx, dtc, discount, drugs the most. They currently have XXXXX followers and X posts still getting attention that total XXXXX engagements in the last XX hours.

### Engagements: XXXXX [#](/creator/twitter::984787662656688128/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::984787662656688128/c:line/m:interactions.svg)

- X Week XXXXXX -XX%
- X Month XXXXXX +303,833%
- X Months XXXXXXX -XX%
- X Year XXXXXXX +335%

### Mentions: X [#](/creator/twitter::984787662656688128/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::984787662656688128/c:line/m:posts_active.svg)

- X Week X +25%
- X Month X +250%
- X Months XX -XX%
- X Year XX +650%

### Followers: XXXXX [#](/creator/twitter::984787662656688128/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::984787662656688128/c:line/m:followers.svg)

- X Week XXXXX +0.34%
- X Months XXXXX +1%
- X Year XXXXX +122%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::984787662656688128/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::984787662656688128/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::984787662656688128/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXXX% [technology brands](/list/technology-brands)  XXXXX% [finance](/list/finance)  XXXXX%

**Social topic influence**
[$vktx](/topic/$vktx) #24, [dtc](/topic/dtc) 22.22%, [discount](/topic/discount) 22.22%, [drugs](/topic/drugs) 22.22%, [$bmy](/topic/$bmy) 22.22%, [$pfe](/topic/$pfe) 22.22%, [pfe](/topic/pfe) 11.11%, [$lly](/topic/$lly) 11.11%, [$hims](/topic/$hims) 11.11%, [$vik](/topic/$vik) XXXXX%

**Top accounts mentioned or mentioned by**
[@alnafisah1994](/creator/undefined) [@krokodil_v](/creator/undefined) [@lfilipecastro](/creator/undefined) [@biopharmiq](/creator/undefined) [@duedoctor](/creator/undefined) [@glptrackerapp](/creator/undefined) [@doctor_salomon](/creator/undefined) [@fat_pockets123](/creator/undefined) [@meadowcapital](/creator/undefined) [@knielsen2000](/creator/undefined) [@brueghelelder87](/creator/undefined) [@trentkelp](/creator/undefined) [@joeyang043](/creator/undefined)

**Top assets mentioned**
[Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Pfizer, Inc. (PFE)](/topic/$pfe) [Eli Lilly and Company (LLY)](/topic/$lly) [Hims & Hers Health, Inc. (HIMS)](/topic/$hims) [Viking Holdings Ltd (VIK)](/topic/$vik) [Amazon.com, Inc. (AMZN)](/topic/$amzn)
### Top Social Posts [#](/creator/twitter::984787662656688128/posts)
---
Top posts by engagements in the last XX hours

"$VKTX- The direct to consumer channel for drugs continues to gain traction with $BMY and $PFE selling Eliquis directly to patients at a XX% discount ➡This DTC channel will continue to gain traction and enable #VK2735 to becoming a blockbuster quickly"  
![@Mufaso7 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::984787662656688128.png) [@Mufaso7](/creator/x/Mufaso7) on [X](/post/tweet/1945811561081131281) 2025-07-17 11:43:22 UTC 3232 followers, 19.8K engagements


"Lots of evidence that GLP1's have positive effects beyond Obesity/T2D. Importantly it sure seems like whenever there is a study evaluating other indications dual agonist GLP1/GIP wins every time vs mono agonist GLP1. 🤔 Here is a link to a recent study on Parkinson's: $LLY $VKTX"  
![@Mufaso7 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::984787662656688128.png) [@Mufaso7](/creator/x/Mufaso7) on [X](/post/tweet/1946884424026493064) 2025-07-20 10:46:32 UTC 3233 followers, 1849 engagements


"$VKTX - The list of possible DTC partners for Viking that would be interested in #VK2735 is long. It includes $HIMS Ro Health $AMZN and Mark Cuban's Cost Plus pharmacy. Some of these companies are even acquire VKTX outright as it gets closer to approval. ➡First Consider that DTC dramatically reduces the cost of obesity drugs making them more affordable by cutting out PBM's. This does so without materially affecting the drug company's margin. ➡Combine that ability with the idea that you don't need a back office team to deal with getting on insurance formulary's. (Obesity drugs are generally"  
![@Mufaso7 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::984787662656688128.png) [@Mufaso7](/creator/x/Mufaso7) on [X](/post/tweet/1945832818363216041) 2025-07-17 13:07:50 UTC 3233 followers, 13.9K engagements


"Bachem $BANB $BANB.SW- a CDMO for peptides posted strong growth in 1st half and is up 27%. Peptides are continuing to gain traction. As they do volumes will go up and costs on a unit basis will decline. $PGTX $VKTX"  
![@Mufaso7 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::984787662656688128.png) [@Mufaso7](/creator/x/Mufaso7) on [X](/post/tweet/1948388031003558328) 2025-07-24 14:21:20 UTC 3233 followers, XXX engagements